• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌危险因素的统计Meta分析及使用人工神经网络算法的风险预测模型的开发

Statistical Meta-Analysis of Risk Factors for Endometrial Cancer and Development of a Risk Prediction Model Using an Artificial Neural Network Algorithm.

作者信息

Hutt Suzanna, Mihaies Denis, Karteris Emmanouil, Michael Agnieszka, Payne Annette M, Chatterjee Jayanta

机构信息

Academic Department of Gynaecological Oncology, Royal Surrey NHS Foundation Trust Hospital, Guildford GU2 7XX, UK.

Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, School of Biosciences and Medicine, University of Surrey, Guildford GU2 7XH, UK.

出版信息

Cancers (Basel). 2021 Jul 22;13(15):3689. doi: 10.3390/cancers13153689.

DOI:10.3390/cancers13153689
PMID:34359595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8345114/
Abstract

OBJECTIVES

In this study we wished to determine the rank order of risk factors for endometrial cancer and calculate a pooled risk and percentage risk for each factor using a statistical meta-analysis approach. The next step was to design a neural network computer model to predict the overall increase or decreased risk of cancer for individual patients. This would help to determine whether this prediction could be used as a tool to decide if a patient should be considered for testing and to predict diagnosis, as well as to suggest prevention measures to patients.

DESIGN

A meta-analysis of existing data was carried out to calculate relative risk, followed by design and implementation of a risk prediction computational model based on a neural network algorithm.

SETTING

Meta-analysis data were collated from various settings from around the world. Primary data to test the model were collected from a hospital clinic setting.

PARTICIPANTS

Data from 40 patients notes currently suspected of having endometrial cancer and undergoing investigations and treatment were collected to test the software with their cancer diagnosis not revealed to the software developers.

MAIN OUTCOME MEASURES

The forest plots allowed an overall relative risk and percentage risk to be calculated from all the risk data gathered from the studies. A neural network computational model to determine percentage risk for individual patients was developed, implemented, and evaluated.

RESULTS

The results show that the greatest percentage increased risk was due to BMI being above 25, with the risk increasing as BMI increases. A BMI of 25 or over gave an increased risk of 2.01%, a BMI of 30 or over gave an increase of 5.24%, and a BMI of 40 or over led to an increase of 6.9%. PCOS was the second highest increased risk at 4.2%. Diabetes, which is incidentally also linked to an increased BMI, gave a significant increased risk along with null parity and noncontinuous HRT of 1.54%, 1.2%, and 0.56% respectively. Decreased risk due to contraception was greatest with IUD (intrauterine device) and IUPD (intrauterine progesterone device) at -1.34% compared to -0.9% with oral. Continuous HRT at -0.75% and parity at -0.9% also decreased the risk. Using open-source patient data to test our computational model to determine risk, our results showed that the model is 98.6% accurate with an algorithm sensitivity 75% on average.

CONCLUSIONS

In this study, we successfully determined the rank order of risk factors for endometrial cancer and calculated a pooled risk and risk percentage for each factor using a statistical meta-analysis approach. Then, using a computer neural network model system, we were able to model the overall increase or decreased risk of cancer and predict the cancer diagnosis for particular patients to an accuracy of over 98%. The neural network model developed in this study was shown to be a potentially useful tool in determining the percentage risk and predicting the possibility of a given patient developing endometrial cancer. As such, it could be a useful tool for clinicians to use in conjunction with other biomarkers in determining which patients warrant further preventative interventions to avert progressing to endometrial cancer. This result would allow for a reduction in the number of unnecessary invasive tests on patients. The model may also be used to suggest interventions to decrease the risk for a particular patient. The sensitivity of the model limits it at this stage due to the small percentage of positive cases in the datasets; however, since this model utilizes a neural network machine learning algorithm, it can be further improved by providing the system with more and larger datasets to allow further refinement of the neural network.

摘要

目的

在本研究中,我们希望确定子宫内膜癌风险因素的排序,并使用统计荟萃分析方法计算每个因素的合并风险和风险百分比。下一步是设计一个神经网络计算机模型,以预测个体患者患癌风险的总体增加或降低情况。这将有助于确定该预测是否可用作决定患者是否应考虑进行检测以及预测诊断的工具,并向患者建议预防措施。

设计

对现有数据进行荟萃分析以计算相对风险,随后基于神经网络算法设计并实施风险预测计算模型。

背景

荟萃分析数据来自世界各地的不同背景。用于测试模型的原始数据是从医院诊所收集的。

参与者

收集了40例目前疑似患有子宫内膜癌并正在接受检查和治疗的患者病历数据,在向软件开发人员隐瞒癌症诊断的情况下对软件进行测试。

主要观察指标

森林图允许根据从研究中收集的所有风险数据计算总体相对风险和风险百分比。开发、实施并评估了一个用于确定个体患者风险百分比的神经网络计算模型。

结果

结果表明,风险增加百分比最大的是BMI高于25,且风险随BMI升高而增加。BMI为25或以上时,风险增加2.01%;BMI为30或以上时,风险增加5.24%;BMI为40或以上时,风险增加6.9%。多囊卵巢综合征(PCOS)是风险增加第二高的因素,为4.2%。糖尿病(其也与BMI升高相关)、未生育以及非连续激素替代疗法(HRT)导致的风险显著增加,分别为1.54%、1.2%和0.56%。避孕措施中,宫内节育器(IUD)和宫内孕激素装置(IUPD)导致的风险降低最大,为-1.34%,而口服避孕药为-0.9%。连续HRT为-0.75%,生育为-0.9%也降低了风险。使用开源患者数据测试我们的计算模型以确定风险,结果表明该模型的准确率为98.6%,算法平均灵敏度为75%。

结论

在本研究中,我们成功确定了子宫内膜癌风险因素的排序,并使用统计荟萃分析方法计算了每个因素的合并风险和风险百分比。然后,使用计算机神经网络模型系统,我们能够模拟患癌风险的总体增加或降低情况,并以超过98%的准确率预测特定患者的癌症诊断。本研究中开发的神经网络模型被证明是确定风险百分比和预测特定患者患子宫内膜癌可能性的潜在有用工具。因此,它可能是临床医生在结合其他生物标志物确定哪些患者需要进一步预防性干预以避免发展为子宫内膜癌时的有用工具。这一结果将减少对患者进行不必要的侵入性检查的数量。该模型还可用于建议降低特定患者风险的干预措施。由于数据集中阳性病例的百分比很小,该模型在现阶段的灵敏度限制了它;然而,由于该模型使用神经网络机器学习算法,可以通过为系统提供更多更大的数据集来进一步改进,以进一步优化神经网络。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/c9b300344fb7/cancers-13-03689-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/17615dff8329/cancers-13-03689-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/e7e39c55dcb7/cancers-13-03689-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/a4b41eef80a9/cancers-13-03689-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/a2e76ead32b8/cancers-13-03689-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/777ca9929380/cancers-13-03689-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/01080e360462/cancers-13-03689-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/1520ff459bc5/cancers-13-03689-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/23947dfa037d/cancers-13-03689-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/cb7156463826/cancers-13-03689-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/5788a94854a0/cancers-13-03689-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/874d18583538/cancers-13-03689-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/56d3cd57f52c/cancers-13-03689-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/c9b300344fb7/cancers-13-03689-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/17615dff8329/cancers-13-03689-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/e7e39c55dcb7/cancers-13-03689-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/a4b41eef80a9/cancers-13-03689-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/a2e76ead32b8/cancers-13-03689-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/777ca9929380/cancers-13-03689-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/01080e360462/cancers-13-03689-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/1520ff459bc5/cancers-13-03689-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/23947dfa037d/cancers-13-03689-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/cb7156463826/cancers-13-03689-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/5788a94854a0/cancers-13-03689-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/874d18583538/cancers-13-03689-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/56d3cd57f52c/cancers-13-03689-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6cb/8345114/c9b300344fb7/cancers-13-03689-g013.jpg

相似文献

1
Statistical Meta-Analysis of Risk Factors for Endometrial Cancer and Development of a Risk Prediction Model Using an Artificial Neural Network Algorithm.子宫内膜癌危险因素的统计Meta分析及使用人工神经网络算法的风险预测模型的开发
Cancers (Basel). 2021 Jul 22;13(15):3689. doi: 10.3390/cancers13153689.
2
Application of artificial intelligence and machine learning for prediction of oral cancer risk.人工智能和机器学习在口腔癌风险预测中的应用。
J Oral Pathol Med. 2021 May;50(5):444-450. doi: 10.1111/jop.13157. Epub 2021 Jan 17.
3
An Applicable Machine Learning Model Based on Preoperative Examinations Predicts Histology, Stage, and Grade for Endometrial Cancer.基于术前检查的适用机器学习模型可预测子宫内膜癌的组织学、分期和分级。
Front Oncol. 2022 May 30;12:904597. doi: 10.3389/fonc.2022.904597. eCollection 2022.
4
5
Significant improvement of miRNA target prediction accuracy in large datasets using meta-strategy based on comprehensive voting and artificial neural networks.基于综合投票和人工神经网络的元策略显著提高了大型数据集中小分子 RNA 靶标预测的准确性。
BMC Genomics. 2019 Feb 27;20(1):158. doi: 10.1186/s12864-019-5528-1.
6
Population-Based Screening for Endometrial Cancer: Human vs. Machine Intelligence.基于人群的子宫内膜癌筛查:人类智能与机器智能
Front Artif Intell. 2020 Nov 24;3:539879. doi: 10.3389/frai.2020.539879. eCollection 2020.
7
8
Endometrial cancer in women with abnormal uterine bleeding: Data mining classification methods.子宫异常出血女性的子宫内膜癌:数据挖掘分类方法
Caspian J Intern Med. 2023 Summer;14(3):526-533. doi: 10.22088/cjim.14.3.526.
9
Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.含孕激素宫内节育器对子宫内膜血管的影响:一项形态计量学研究。
Am J Obstet Gynecol. 1981 Dec 1;141(7):821-7. doi: 10.1016/0002-9378(81)90711-0.
10

引用本文的文献

1
Effects of Asprosin and Role of TLR4 as a Biomarker in Endometrial Cancer.阿扑脂蛋白A的作用及Toll样受体4作为子宫内膜癌生物标志物的作用
Molecules. 2025 Aug 18;30(16):3410. doi: 10.3390/molecules30163410.
2
Artificial intelligence in the diagnosis and management of gynecologic cancer.人工智能在妇科癌症的诊断与管理中的应用
Int J Gynaecol Obstet. 2025 Apr 25. doi: 10.1002/ijgo.70094.
3
The Association Between Metabolic Syndrome and the Risk of Endometrial Cancer in Pre- and Post-Menopausal Women: A UK Biobank Study.绝经前后女性代谢综合征与子宫内膜癌风险的关联:一项英国生物银行研究

本文引用的文献

1
New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines.基于更新后的ESGO/ESTRO/ESP指南看子宫内膜癌的新病理及临床见解
Cancers (Basel). 2021 May 26;13(11):2623. doi: 10.3390/cancers13112623.
2
Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.左炔诺孕酮宫内节育系统的使用与降低卵巢癌和子宫内膜癌的风险有关,而不会增加乳腺癌的风险。NOWAC 研究的结果。
Gynecol Oncol. 2018 Apr;149(1):127-132. doi: 10.1016/j.ygyno.2018.02.006. Epub 2018 Mar 2.
3
J Clin Med. 2025 Jan 24;14(3):751. doi: 10.3390/jcm14030751.
4
Models for predicting risk of endometrial cancer: a systematic review.子宫内膜癌风险预测模型:一项系统评价。
Diagn Progn Res. 2025 Feb 4;9(1):3. doi: 10.1186/s41512-024-00178-0.
5
A risk prediction model for endometrial hyperplasia/endometrial carcinoma in premenopausal women.一种针对绝经前女性子宫内膜增生/子宫内膜癌的风险预测模型。
Sci Rep. 2025 Jan 6;15(1):1019. doi: 10.1038/s41598-024-83568-0.
6
A Population-Based Analysis of the Cancer Incidence in Individuals under 50 in a Northern Italian Province: Focusing on Regional Disparities and Public Health Implications.基于人群的意大利北部一省 50 岁以下人群癌症发病率分析:关注区域差异和公共卫生影响。
Int J Environ Res Public Health. 2024 Oct 8;21(10):1333. doi: 10.3390/ijerph21101333.
7
In Silico and In Vitro Mapping of Receptor-Type Protein Tyrosine Phosphatase Receptor Type D in Health and Disease: Implications for Asprosin Signalling in Endometrial Cancer and Neuroblastoma.健康与疾病中受体型蛋白酪氨酸磷酸酶D的计算机模拟和体外定位:对子宫内膜癌和神经母细胞瘤中阿朴脂蛋白信号传导的影响
Cancers (Basel). 2024 Jan 30;16(3):582. doi: 10.3390/cancers16030582.
8
Optimizing Outcomes through a Multidisciplinary Team Approach in Endometrial Cancer.通过多学科团队方法优化子宫内膜癌治疗效果
Healthcare (Basel). 2023 Dec 27;12(1):64. doi: 10.3390/healthcare12010064.
9
Endometrial cancer in women with abnormal uterine bleeding: Data mining classification methods.子宫异常出血女性的子宫内膜癌:数据挖掘分类方法
Caspian J Intern Med. 2023 Summer;14(3):526-533. doi: 10.22088/cjim.14.3.526.
10
An Assessment of the Predictive Performance of Current Machine Learning-Based Breast Cancer Risk Prediction Models: Systematic Review.基于当前机器学习的乳腺癌风险预测模型的预测性能评估:系统评价。
JMIR Public Health Surveill. 2022 Dec 29;8(12):e35750. doi: 10.2196/35750.
Effects of metformin on endometrial cancer: Systematic review and meta-analysis.
二甲双胍对子宫内膜癌的影响:系统评价与荟萃分析
Gynecol Oncol. 2017 Oct;147(1):167-180. doi: 10.1016/j.ygyno.2017.07.120. Epub 2017 Jul 29.
4
Identifying High-Risk Women for Endometrial Cancer Prevention Strategies: Proposal of an Endometrial Cancer Risk Prediction Model.识别子宫内膜癌预防策略的高危女性:子宫内膜癌风险预测模型的建议
Cancer Prev Res (Phila). 2017 Jan;10(1):1-13. doi: 10.1158/1940-6207.CAPR-16-0224. Epub 2016 Dec 13.
5
Body size over the life-course and the risk of endometrial cancer: the California Teachers Study.一生中的身体大小与子宫内膜癌风险:加利福尼亚教师研究
Cancer Causes Control. 2016 Dec;27(12):1419-1428. doi: 10.1007/s10552-016-0820-8. Epub 2016 Nov 1.
6
Hormone replacement therapy and the risk of endometrial cancer: A systematic review.激素替代疗法与子宫内膜癌风险:一项系统评价。
Maturitas. 2016 Sep;91:25-35. doi: 10.1016/j.maturitas.2016.05.013. Epub 2016 Jun 1.
7
Body Mass Index Is Positively Associated with Endometrial Cancer in Chinese Women, Especially Prior to Menopause.在中国女性中,体重指数与子宫内膜癌呈正相关,尤其是在绝经前。
J Cancer. 2016 Jun 6;7(9):1169-73. doi: 10.7150/jca.15037. eCollection 2016.
8
Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.体重指数在决定是否进行子宫内膜活检方面比年龄更具影响力:有症状的绝经前女性队列研究
Am J Obstet Gynecol. 2016 Nov;215(5):598.e1-598.e8. doi: 10.1016/j.ajog.2016.06.006. Epub 2016 Jun 8.
9
Prospective cohort study of general and central obesity, weight change trajectory and risk of major cancers among Chinese women.中国女性总体和中心性肥胖、体重变化轨迹与主要癌症风险的前瞻性队列研究。
Int J Cancer. 2016 Oct 1;139(7):1461-70. doi: 10.1002/ijc.30187. Epub 2016 May 31.
10
Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies.三项病例对照研究的汇总分析中体重指数与子宫内膜癌风险的建模
BJOG. 2016 Jan;123(2):285-92. doi: 10.1111/1471-0528.13717. Epub 2015 Nov 6.